Skip to main content
Caplight Logo









SCBIO

SCBIO

Private
DaejeonHealthcare & Life Scienceshttp://sc-bio.co.kr/

Last Round

Series B

Sep 1, 2025

Total Funding Raised

$23.1M

Company Overview

SCBIO is a biotechnology company that discovers and develops novel small-molecule therapeutics with a focus on immuno-oncology and fibrosis treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug discoveryimmuno-oncologyantibody-drug conjugateADCpulmonary fibrosisbiotechsmall-molecule drugsorphan drugpreclinical testingtechnology licensingL/Obiopharmadrug pipelinepharmaceutical R&Dtherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SCBIO Comparables

Compare SCBIO with similar companies based on industry and business-model similarity.

SCBIO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avelos Therapeutics
85%
Nextgen Bioscience Co., Ltd.
82%
Wellmarker Bio
82%

SCBIO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 1, 2025
Series AMay 18, 2023
Pre SeedAug 19, 2022

SCBIO Investors

Notable investors and investment history

SCBIO investors
InvestorRounds
KOTECPre Seed
Korea University HoldingsPre Seed
A VenturesSeries A
SL InvestmentSeries B
iM Investment PartnersSeries B
XquaredSeries B
TS InvestmentSeries A

SCBIO Filings

Explore SEC and related filing metadata, where available.

SCBIO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about SCBIO's valuation, stock price, and market status.

Is SCBio a public or private company?

SCBio is a private company.

What is the current stock price of SCBio?

SCBio is a private company with no public stock price. No recent secondary market data is available.

How much is SCBio worth (valuation)?

Valuation information for SCBio is not publicly available.

Can I buy SCBio stock?

SCBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was SCBio's last funding round?

SCBio's most recent funding round was Series B on September 1, 2025.

Who are the main investors in SCBio?

Key investors in SCBio include Union Investment.

Will SCBio IPO soon?

No public IPO plans have been announced for SCBio.

How can I track SCBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SCBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaejeon
Year Founded2021
Last FundingSep 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?